Session 3 "Analyzer Workshop" evolution of therapeutic strategies in Parkinson's disease

J Neurol. 2004 Oct:251 Suppl 7:vII24-30. doi: 10.1007/s00415-004-1707-2.
No abstract available

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use
  • Diagnosis, Differential
  • Guideline Adherence*
  • Humans
  • Levodopa / therapeutic use
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / therapy*
  • Practice Guidelines as Topic*
  • Practice Patterns, Physicians' / statistics & numerical data

Substances

  • Antiparkinson Agents
  • Levodopa